NAV

F-Loop of Vitamin B12

Identification

Generic Name
F-Loop of Vitamin B12
DrugBank Accession Number
DB02576
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 76.1176
Monoisotopic: 76.076238947
Chemical Formula
C3H10NO
Synonyms
Not Available
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UMethylaspartate mutase S chainNot AvailableClostridium tetanomorphum
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as 1,2-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom.
Kingdom
Organic compounds
Super Class
Organic nitrogen compounds
Class
Organonitrogen compounds
Sub Class
Amines
Direct Parent
1,2-aminoalcohols
Alternative Parents
Secondary alcohols / Organopnictogen compounds / Monoalkylamines / Hydrocarbon derivatives / Organic cations
Substituents
1,2-aminoalcohol / Alcohol / Aliphatic acyclic compound / Hydrocarbon derivative / Organic cation / Organic oxygen compound / Organooxygen compound / Organopnictogen compound / Primary aliphatic amine / Primary amine
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
UE40BY1BZW
CAS number
78-96-6
InChI Key
HXKKHQJGJAFBHI-VKHMYHEASA-O
InChI
InChI=1S/C3H9NO/c1-3(5)2-4/h3,5H,2,4H2,1H3/p+1/t3-/m0/s1
IUPAC Name
(2S)-2-hydroxypropan-1-aminium
SMILES
C[C@H](O)C[NH3+]

References

General References
Not Available
PubChem Compound
7311735
PubChem Substance
46506822
ChemSpider
5641721
PDBe Ligand
FOP

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)24-26 °CPhysProp
boiling point (°C)160 °CPhysProp
water solubility1E+006 mg/LK-O CHEM ENCYCL 4th ed 2:3 (1992)
logP-0.96HANSCH,C ET AL. (1995)
pKa9.94 (at 10 °C)PERRIN,DD (1972)
Predicted Properties
PropertyValueSource
Water Solubility99.9 mg/mLALOGPS
logP-2.7ALOGPS
logP-0.9Chemaxon
logS-0.05ALOGPS
pKa (Strongest Acidic)15.3Chemaxon
pKa (Strongest Basic)9.6Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count1Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area47.87 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity31.92 m3·mol-1Chemaxon
Polarizability8.77 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.7833
Blood Brain Barrier+0.6825
Caco-2 permeable-0.5986
P-glycoprotein substrateNon-substrate0.6691
P-glycoprotein inhibitor INon-inhibitor0.9597
P-glycoprotein inhibitor IINon-inhibitor0.8707
Renal organic cation transporterNon-inhibitor0.9246
CYP450 2C9 substrateNon-substrate0.8146
CYP450 2D6 substrateNon-substrate0.7812
CYP450 3A4 substrateNon-substrate0.7755
CYP450 1A2 substrateNon-inhibitor0.8993
CYP450 2C9 inhibitorNon-inhibitor0.9392
CYP450 2D6 inhibitorNon-inhibitor0.8657
CYP450 2C19 inhibitorNon-inhibitor0.9277
CYP450 3A4 inhibitorNon-inhibitor0.965
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9415
Ames testAMES toxic0.5863
CarcinogenicityNon-carcinogens0.555
BiodegradationReady biodegradable0.9452
Rat acute toxicity1.8894 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.7738
hERG inhibition (predictor II)Non-inhibitor0.8804
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-001i-9000000000-37aad786b5eb4f970887
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-120.52209
predicted
DeepCCS 1.0 (2019)
[M+H]+122.4175
predicted
DeepCCS 1.0 (2019)
[M+Na]+130.3459
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. Methylaspartate mutase S chain
Kind
Protein
Organism
Clostridium tetanomorphum
Pharmacological action
Unknown
General Function
Methylaspartate mutase activity
Specific Function
Catalyzes the carbon skeleton rearrangement of L-glutamate to L-threo-3-methylaspartate ((2S,3S)-3-methylaspartate).
Gene Name
glmS
Uniprot ID
Q05488
Uniprot Name
Glutamate mutase sigma subunit
Molecular Weight
14747.8 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at August 01, 2020 13:43